Pseudogene CSPG4P12 inhibits colorectal cancer progression by attenuating epithelial-mesenchymal transition

Qinqin Song,Hongxue Xu,Hongjiao Wu,Jing Dong,Shanshan Ji,Xuemei Zhang,Zhi Zhang,Wanning Hu
DOI: https://doi.org/10.1590/1414-431x2024e13645
2024-05-29
Brazilian Journal of Medical and Biological Research
Abstract:Song, Qinqin ; Xu, Hongxue ; Wu, Hongjiao ; Dong, Jing ; Ji, Shanshan ; Zhang, Xuemei ; Zhang, Zhi ; Hu, Wanning ; Colorectal cancer is one of the most common malignant cancers. Pseudogenes have been identified as oncogenes or tumor suppressor genes in the development of various cancers. However, the function of pseudogene CSPG4P12 in colorectal cancer remains unclear. Therefore, the aim of this study was to investigate the potential role of CSPG4P12 in colorectal cancer and explore the possible underlying mechanism. The difference of CSPG4P12 expression between colorectal cancer tissues and adjacent normal tissues was analyzed using the online Gene Expression Profiling Interactive Analysis 2 (GEPIA2) database. Cell viability and colony formation assays were conducted to evaluate cell viability. Transwell and wound healing assays were performed to assess cell migration and invasion capacities. Western blot was used to measure the expression levels of epithelial-mesenchymal transition-related proteins. Colorectal cancer tissues had lower CSPG4P12 expression than adjacent normal tissues. The overexpression of CSPG4P12 inhibited cell proliferation, invasion, and migration in colorectal cancer cells. Overexpressed CSPG4P12 promoted the expression of E-cadherin, whereas it inhibited the expression of vimentin, N-cadherin, and MMP9. These findings suggested that CSPG4P12 inhibits colorectal cancer development and may serve as a new potential target for colorectal cancer.
medicine, research & experimental,biology
What problem does this paper attempt to address?